A forum representing the Indian biotechnology sector has inked a memorandum of understanding (MoU) with Japan’s Forum for Innovative Regenerative Medicine (FIRM) to accelerate research on regenerative medicine.
The partnership between the Association of Biotechnology Led Enterprises (ABLE) and FIRM is a unique platform to advance and promote commercialisation of life-saving products in regenerative medicine in both the countries.
The collaborative programmes between ABLE and FIRM will focus on advancing the individual and common missions by sharing information including technology, policy, partnerships and opportunities such as co-sponsoring meetings and other cooperation based on common concern. The MoU was signed by P. Manohar, Head of the Committee for Regenerative Medicine Group of ABLE and FIRM chairman Yuzo Toda.
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.